Movie S1 Time-lapse movie of CD34+ cells co-cultured with GalT-GFP expressing osteoblasts.
Haematopoietic stem-progenitor cells (HSPCs) reside in the bone marrow niche, where interactions with osteoblasts provide essential cues for their proliferation and survival.
Here, we use live-cell imaging to characterize both the site of contact between osteoblasts and haematopoietic progenitor cells (HPCs) and events at this site that result in downstream signalling responses important for niche maintenance. HPCs made prolonged contact with the osteoblast surface through a specialized membrane domain enriched in prominin 1, CD63 and rhodamine PE. At the contact site, portions of the specialized domain containing these molecules were taken up by the osteoblast and internalized into SARA-positive signalling endosomes. This caused osteoblasts to downregulate Smad signalling and increase production of stromal-derived factor-1 (SDF-1), a chemokine responsible for HSPC homing to bone marrow. These findings identify a mechanism involving intercellular transfer to signalling endosomes for targeted regulation of signalling and remodelling events within an ex vivo osteoblastic niche.
The bone marrow provides the regulatory microenvironment or niche for the proliferation and survival of HSPCs 1 , which give rise to all blood and immune cells and repopulate bone marrow after stem-cell transplantation. HPCs traffic between the blood circulation and the bone marrow, moving on and off niche sites 1, 2 . Osteoblasts, which reside in the bone marrow, are key participants in providing cues for HPC trafficking, proliferation and survival through the secretion of cell-signalling molecules, including SDF-1 (ref. 3) . Osteoblasts also make intimate physical contact with HPCs, modulating their function in response to specific physiological conditions 4, 5 . Contact-dependent communication between HPCs and osteoblasts is essential for establishment and maintenance of progenitor cell proliferation and self-renewal [5] [6] [7] [8] , but the molecular pathways that govern this interaction are largely unknown. Moreover, the downstream events occurring at the HPC-osteoblast contact site remain uncharacterized, despite their major role in signalling and remodelling within the niche.
To investigate the morphological and functional characteristics of the HPC-osteoblast interface, we imaged a live-cell, co-culture system consisting of either primary human CD34 + cells or cells from the human KG1a progenitor cell line, co-cultured with the human SaOS2 osteoblastic cell line or primary human osteoblasts. HPCs (that is, CD34 + and KG1a cells) showed a rapidly changing morphology and were motile, often with a leading and lagging edge, or uropod, as described previously 9,10 ( Fig. 1a ; Supplementary Information, Movie 1). Following movement towards and between osteoblasts, individual HPCs were observed making contact and adhering to osteoblasts ( Fig. 1b ; Supplementary Information, Movie 2). Given that this HPC behaviour fits previous descriptions, we began a detailed examination of the cell contact interface and its dynamics.
The surface distribution of different HPC plasma membrane components was investigated as this may be important for HPC interactions with osteoblasts. The very late antigen-4 (VLA-4) protein, which interacts with VCAM-1 (ref. 8) , was highly enriched within a specialized membrane domain of HPCs ( Fig. 1c ) regardless of contact with osteoblasts. A similar asymmetric distribution was seen for CD63 ( Fig. 1d ) and CD81 ( Fig. 1e ), which are tetraspanins implicated in integrin regulation 11, 12 . The stem and progenitor cell marker, prominin 1, which localizes to highly curved membranes 13, 14 , also showed the polarized pattern ( Fig. 1f , f´), as did the fluorescent phosphatidylethanolamine analogue, N-Rh-PE (1,2-dipalmitoyl-sn-glycero-3-phophoethanolamine-N-[lissamine rhodamine B sulfonyl]; Fig. 1g , g´, g´´ ), a cone-shaped lipid that inserts within the plasma membrane 15 . N-Rh-PE-labelling of a more enriched population of HSPCs, human CD34 + CD38cells, showed a polarized distribution in 97% of the cells (n = 115 cells). Quantum dot (QD)-labelling of HPCs also showed clustering within the membrane domain ( Fig. 1h ). This presumably occurred by QD clustering along the plasma membrane or potentially by a capping event, rather than by internalized delivery, as QDs could be removed by proteinase K digestion (data not shown). The polarized localization of these markers was specific because other surface molecules, CD34 ( Fig. 1i ) and CD45 ( Fig. 1j ), were distributed throughout the plasma membrane. Therefore, HPCs are highly polarized and contain a specialized membrane domain with specific protein and lipid components.
l e t t e r s
To better understand HPC surface polarity and, ultimately, the importance of asymmetry for events occurring at the HPC-osteoblast interface, cholesterol depletion was performed using the cholesterol-sequestering agent, methyl-β-cyclodextrin. After methyl-β-cyclodextrin treatment, molecules normally enriched in the specialized domain, including prominin 1-GFP, CD63-Cherry and N-Rh-PE ( Fig. 1k-m (a-b) HPC dynamics are revealed by time-lapse confocal microscopy of CD34 + cells co-cultured with osteoblasts stably transfected with GalT-YFP (green, a) or KG1a cells labelled with PKH26 (red) and co-cultured with osteoblasts transiently expressing PH-Akt-GFP (green, b). (c-e, i, j) Immunofluorescence labelling of KG1a cells with antibodies for VLA4 (c), CD63 (d) and CD81 (e) illustrates an asymmetric distribution of membrane proteins, whereas CD34 (i) and CD45 (j) are distributed more uniformly in the plasma membrane. (h) Live-cell imaging of CD34 + cells labelled with cell-labelling QDs (red). (f-g´´)Live-cell microscopy of CD34 + (f, g) or KG1a (f´, g´) cells transiently transfected with prominin 1-GFP (green) or 24 h after N-Rh-PE labelling (red). These images are representative of the polarized molecule phenotype observed in more than 100 HPCs expressing prominin 1-GFP and more than 200 HPCs labelled with N-Rh-PE. Live-cell microscopy of CD34 + CD38cells 24 h after N-Rh-PE-labelling is shown in g´´. (k-s) Live-cell microscopy of KG1a cells labelled with N-Rh-PE or transiently transfected with CD63-Cherry, or prominin 1-GFP and then treated with vehicle control (k, l, m), methyl β cyclodextrin (MβCD, 10 mM) for 30 min at 37 °C (n, o, p), or cytocholasin D (Cyto D, 2 μm) for 1 h at 37 °C (q, r, s). N-Rh-PE was polarized in 92% of the cells treated with vehicle control, 20% of the cells treated with MβCD, and 40% of the cells treated with Cyto D (n >100 cells for each condition). After these various drug treatments, KG1a cell viability was greater than 95%, as assessed by trypan blue staining (data not shown). Scale bars, 5 μm (a-s). l e t t e r s into punctate clusters across the plasma membrane ( Fig. 1n -p). Actin destabilization using cytochalasin D treatment also disrupted the domain organization, resulting in prominin 1-GFP, CD63-Cherry and N-Rh-PE dispersing throughout the plasma membrane ( Fig. 1q-s ). Hence, cholesterol and actin-based processes are important for the polarized domain localization of HPC surface components.
On contact with an osteoblast ( Fig. 2a, h) , an HPC (red) often remained attached to the same osteoblast (green) for more than 5 h ( Fig. 2a ; Supplementary Information, Movie 2). Confocal z series imaging revealed that the HPC contact site was often mediated by the uropod, which resided in close association with the osteoblast plasma membrane ( Fig. 2b-d , xz images) 9, 16 . Interestingly, the specialized membrane domain components, including prominin 1-GFP ( Fig. 2b) , N-Rh-PE ( Fig. 2c ), VLA-4 ( Fig. 2e ) and CD63-Cherry ( Fig. 2f ), were all highly enriched at the contact site or uropod, in contrast to CD45 ( Fig. 2g ), which remained dispersed over the HPC surface. In QD-labelled HPCs, the QDs also clustered at the contact site ( Fig. 2d ). Time-lapse imaging of N-Rh-PE-labelled CD34 + CD38cells co-cultured with primary human osteoblasts further established the polarized N-Rh-PE domain as the site of cell-cell contact ( Supplementary Information, Movie 3) . Scanning electron microscopy (SEM) of the contact interface revealed the presence of microvilli-like projections on the HPC membrane, similar to those described previously 16 (Fig. 2h , i). The contact zone of the HPC seen in the SEM images consisted of a region several microns in diameter, with the microvilli in this zone seeming to almost penetrate the osteoblast at the contact site ( Fig. 2i, see arrows) . Nanotube-like structures projecting from many HPCs were also observed making contact with osteoblasts, but were distinct from the contact interface ( Fig. 2j, k) . Thus, the HPC-osteoblast contact site is an elaborate, often microvilli-rich, region containing stem-cell markers (that is, prominin1) and adhesion-signalling molecules (that is, VLA4, CD63 and CD81).
To study the contact-site membrane dynamics, we imaged QD-labelled HPCs in contact with osteoblastic cells. Strikingly, QDs transferred from the HPC uropod into the cytoplasm of tubulin-YFP-expressing osteoblasts ( Fig. 3a ; Supplementary Information, Movie 4) . The cytoplasmic localization of the transferred QDs was confirmed by z series confocal imaging through the osteoblast, which showed that the QDs were in the same plane as the intercellular marker, tubulin-YFP, and not detected on the osteoblast surface ( Fig. 3a, zoom ). This suggests that intercellular transfer was occurring at the contact site. Imaging of prominin 1-GFPlabelled HPCs in contact with osteoblasts revealed punctate structures enriched in the marker being transferred to the osteoblast over a 20-min contact period (Fig. 3b ). Unlike QDs, which reside peripherally on the surface of HPCs and so may be transferred to osteoblasts by a sticking and release process, prominin 1-GFP is embedded in the HPC bilayer and so can only be transferred along with HPC membrane. Co-culturing of CD63-Cherry-labelled HPCs with tubulin-YFP osteoblasts also revealed uptake of CD63-Cherry into the osteoblast ( Fig. 3c ; Supplementary Information, Movie 5). Because both prominin 1-GFP and CD63-Cherry proteins were engineered with the fluorescent proteins fused to the carboxy terminus, which is located in the cytosol, their detection in the osteoblast cells after transfer from HPCs suggests that the entire protein was transferred, not a cleaved fragment. Intercellular transfer of N-Rh-PE into osteoblasts also occurred when N-Rh-PE-labelled HPCs contacted osteoblasts (Fig. 3d ). This indicates that both lipid and protein components from the HPC uropod were transferred to osteoblasts.
Efficient intercellular transfer did not occur when HPCs were co-cultured with a non-niche cell type. For example, when N-Rh-PE-labelled HPCs were co-cultured with HeLa cells for up to 3 h, only about 20% of the HeLa cells showed evidence of transfer ( Fig. 3e ). By contrast, more than 80% of osteoblastic cells contacting HPCs became labelled within 3 h of co-culturing ( Fig. 3e ). As no transferred HPC molecules were observed in neighbouring osteoblasts not contacting a labelled HPC during 1 h of co-culture ( Fig. 3f, g) , efficient molecular transfer only occurred between HPCs and osteoblasts that made direct cell contact. In addition, co-culturing of HPCs and osteoblasts separated by a 0.4-μm membrane filter revealed no molecular transfer from HPCs to osteoblasts during 3 h of co-culture (Fig. 3g ). This argues against transfer by bulk cellular release of exosomes, which are small membrane vesicles about 50-100 nm in diameter 17 . Instead, the observed transfer seemed to be mediated by specific events occurring at the HPC-osteoblast contact site.
To investigate the importance of the specialized membrane domain or uropod in intercellular transfer, this region was disrupted using methyl-β-cyclodextrin or cytochalasin D treatment, as described before. Transfer between a contacting HPC and osteoblast was assessed by livecell imaging of N-Rh-PE-labelled HPCs pretreated with these reagents and then co-cultured with osteoblasts for 1 h. The level of intercellular transfer between contacting cells was significantly reduced (Fig. 3h) , indicating that efficient intercellular transfer requires contact of the specialized HPC uropod domain with osteoblasts.
HPC uropod domain components were transferred into punctate compartments inside the osteoblast without being noticeably diluted (see Fig. 3b for prominin 1-GFP). This suggests that intercellular transfer did not involve fusion of the HPC uropod with the osteoblast plasma membrane, as transferred components would disperse into the plasma membrane. Instead, transfer seemed to occur by a cytophagocytosis event, in which portions of the HPC uropod domain were engulfed by the osteoblast. This was most convincingly shown in co-cultures of primary CD34 + cells and osteoblasts. There, an entire domain enriched in N-Rh-PE of the primary CD34 + cell could be seen being transferred to the osteoblast over a short transfer period, leaving the cell depleted of N-Rh-PE ( Fig. 3i; Supplementary Information,  Movie 6 ). The N-Rh-PE domain transfer was also detected from the more primitive CD34 + CD38cells to primary human osteoblasts (Fig. 3j ). Addition of dynasore, an inhibitor of the endocytic effector protein dynamin 18, 19 , to the co-culture system significantly reduced the amount of uptake of HPC components at the contact site ( Fig. 3h ), suggesting that the intercellular transfer mechanism was dynamindependent.
We next followed the fate of transferred material taken up by the osteoblast. After 30 min of uptake, HPC components were seen in various osteoblast endocytic compartments, including Rab5-and Rab7-positive structures (Fig. 4a-c ). In addition, HPC components were observed in endocytic structures positive for the 2×FYVE domain 20 (Fig. 4c, d) .
Imaging of single osteoblasts that had taken up prominin 1-GFP from a contacting HPC (Fig. 4e ) showed that the transferred molecules remained in distinct intracellular structures within the osteoblast for up to 12 h post-transfer. In contrast, endocytosed EGF and the soluble amyloid β protein, which are delivered to lysosomes for degradation 21 , were completely destroyed by the osteoblast during a similar time period (Fig. 4f) . These results suggest that although transferred molecules could be degraded, a proportion of these molecules avoided destruction within osteoblast lysosomes and were delivered through endocytic intermediates to a longer-lived intracellular compartment.
To determine the significance of transferred molecule localization for cell communication between HPC and osteoblast, we further characterized the endocytic structures containing transferred molecules. In particular, we focused on the endocytic structures that were positive for the 2×FYVE domain-GFP, as many FYVE-domain-containing proteins are involved in signal transduction 22 . SARA (Smad anchor for receptor activation) is a FYVE domain-containing protein localized to endosomes, which correspond to a signalling compartment specialized for the propagation of extracellular signals such as TGFβ signalling 23, 24 . Upon TGFβ receptor activation, Smads are translocated to the nucleus with the help of the cofactor, SARA, resulting in gene activation. Osteoblasts fixed after N-Rh-PE transfer and stained using SARA-specific antibodies showed significant colocalization of N-Rh-PE with SARA-labelled endosomes (Fig. 5a ). The histogram of the weighted colocalization coefficients (Fig. 5b) revealed a similar level of N-Rh-PE colocalization with SARA as with Rab 7, although SARA and Rab 7 seemed to represent two different populations of endosomes. These data show that molecules transferred from the HPC membrane domain can be delivered to a SARA-positive signalling endosome within osteoblasts.
SARA endosomes are known to signal through Smad activation 25, 26 . Therefore, Smad signalling was tested in the presence of transferred molecules in the osteoblasts. Osteoblasts without a transfer event, or osteoblasts cultured without HPCs, showed a high nuclear localization of Smad2/3, suggesting activated Smad signalling (Fig. 5c ). In contrast, osteoblasts with detectable N-Rh-PE transfer primarily had a cytoplasmic localization of Smad2/3 (Fig. 5d ), consistent with a reduction in activated Smad2/3 signalling. Quantification of the nuclear-cytoplasmic intensity ratio of Smad2/3 confirmed that Smad nuclear localization, and therefore TGFβ signalling, was diminished in osteoblasts following a N-Rh-PE transfer event (Fig. 5e ). 5 μm (a, b, d, e ).
Previous studies have suggested that TGFβ1 signalling can be inhibitory to osteoblast maintenance of HPCs by downregulating a specific chemokine, SDF-1 (refs 27, 28), produced by osteoblasts. SDF-1, also referred to as CXCL12, is known to modulate progenitor cell migration and adhesion 3, 29 . Immunofluorescence showed that approximately 30% of the osteoblasts in culture expressed detectable SDF-1 (Fig. 5f ). This finding is consistent with the osteoblasts having activated TGFβ1 signalling and the observed high levels of nuclear Smad2/3 (Fig. 5c, d ). We hypothesized that if the intercellular transfer event is reducing TGFβ1 signalling, we may observe a subsequent increase in SDF-1-expressing osteoblasts specifically following intercellular transfer. After 1 h of coculture, 45% of the osteoblasts containing transferred material expressed SDF-1 (Fig. 5f ). Figure 5g shows an example of an SDF-1 expressing osteoblast (green) after uptake of N-Rh-PE (red) from an HPC. When the time of co-culture was increased to 5 h, almost 75% of the osteoblasts with a transfer event were expressing SDF-1 (Fig. 5f ). Therefore, after prolonged co-culture, osteoblasts positive for transferred N-Rh-PE were also positive for SDF-1 expression.
To discriminate between induction of SDF-1 expression by the transfer event or by continued KG1a cell contact, we washed the KG1a cells from the osteoblastic monolayer after 1 h of co-culture. After HPC removal, the osteoblasts were cultured for an additional 4 h to evaluate SDF-1 expression. Once again, approximately 75% of osteoblasts with a transfer event were positive for SDF-1 expression ( Fig. 5h ). Therefore prolonged HPC contact with osteoblasts is not required for the observed SDF-1 induction. To address whether transfer is specifically required for the SDF-1 induction, we treated the HPC-osteoblast co-cultures for 1 h with methyl β cyclodextrin (10 mM), cytocholasin D (2 μm) or dynasore (80 μm), which reduced N-Rh-PE transfer (Fig. 3h ). Drug treatment, which allows for osteoblast contact but reduces transfer, resulted in a decreased number of SDF-1-expressing osteoblasts when compared with control co-cultures. These data suggest that intercellular transfer is required for the changes in protein expression within osteoblastic cells, more specifically to an increased production of SDF-1.
In this paper, we have identified events occurring after HPC-osteoblast contact that may have important roles in signalling and remodelling events in the bone marrow niche. Specifically, we show that portions of the HPC uropod membrane at the contact site are actively endocytosed by osteoblasts and delivered to SARA-positive, signalling endosomes. In response to intercellular transfer, osteoblasts show decreased Smad signalling and greater production of the bone marrow chemokine SDF-1. This may occur because the transferred material within SARAendosomes sequesters SARA away from its general co-factor function in Smad activation, allowing the osteoblast to produce more SDF-1. These events could greatly influence the overall trafficking, proliferation and survival of HSPCs in the bone marrow niche by permitting signalling events to be initiated and propagated at the single-cell level. Furthermore, the intercellular transfer and downstream endosomal signalling described in this study could be significant for cell-cell communication not only in the bone marrow, but also in other intimate cellular microenvironments [30] [31] [32] .
METHODS
Cells and transfection. The KG1a cell line and the SaOS2 cell line (American Type Culture Collection) were cultured in RPMI 1640 supplemented with 10% FBS, sodium pyruvate, non-essential amino acids, sodium bicarbonate and MEM vitamins (Invitrogen). Primary human osteoblast (hOST cells) were purchased from Lonza and cultured according to manufacturer's protocol. Human CD34 + cells were collected from normal healthy volunteers who gave informed consent in accordance with the Declaration of Helsinki and National Institutes of Health Institutional Review Board-approved protocols. Donors received G-CSF (10 μg kg -1 , Filgrastim) for 5 days, given as a single daily subcutaneous injection with leukapheresis initiated on the morning of day 5. Large volume (15 l) leukapheresis procedures were performed with a model CS-3000 Plus continuous-flow apheresis device (Fenwal Division). The apheresis products were enriched for CD34 + cells by immunomagnetic bead affinity elution with a magnetic cell selection system (Isolex 300I, Nexell Therapeutics). In some experiments, human CD34 + CD38cells were enriched by FACS with anti-CD34-PE (Becton Dickinson) and anti-CD38-PECy7 (Becton Dickinson) antibodies using a FACS Aria II instrument (Becton Dickinson).
Transfection. KG1a and CD34 + cells were nucleofected in accordance with the manufacturer's protocol (Amaxa, Lonza Group) with CD63-Cherry or with prominin 1-GFP. SaOS2 cells were transfected with PH-Akt-GFP, 2×FYVE-GFP, clathrin light chain-YFP, Rab5-GFP or Rab7-GFP using the Fugene 6 reagent according to the manufacturer's protocol (Roche). Previously, actin-YFP, tubulin-GFP and pEGFP SaOS2 stable cell lines were generated by G418 selection.
HPC labelling. Cells were labelled with N-Rh-PE by incubating with N-Rh-PE (5 μM, Avanti Polar Lipids) diluted in cold 1× Hanks buffer (Invitrogen) for 1 h on ice. Cells were then washed three times with cold Hanks buffer before plating back into growth medium. N-Rh-PE-labelled cells were used in co-culture experiments approximately 24 h after labelling. HPCs were labelled with cell labelling QDs according to the manufacturer's instructions (Invitrogen), except that the cell and QD incubation time was extended to overnight. PKH26-labelling was performed according to manufacturer's protocol (Sigma).
Live-cell imaging. SaOS2 cells were plated on collagen I (BD Biosciences) precoated 4-or 8-well chambered coverglasses (Nunc; Thermo Fisher Scientific). For transient transfections, SaOS2 cells were transfected in the chambered coverglasses 24 h before co-culturing and imaging. Cells were imaged at 37 °C in either CO 2 -independent medium supplemented with 10% FBS (Invitrogen) or with mineral oil overlaid on the culture medium to reduce gas exchange. Cells were imaged by laser scanning confocal microscopy with Zeiss LSM 510 systems (Zeiss) using excitation wavelengths of 488 or 543 nm and a ×63 oil immersion objective (NA = 1.2). Image analysis was performed using the Zeiss LSM 510 software or Image J (NIH, Bethesda, MD). Brightness and contrast were changed in some brightfield images to increase cell visibility (Adobe Photoshop).
For intercellular transfer experiments, HPCs and osteoblasts were co-cultured for 1 h on the microscope before imaging. After co-culture, z series confocal imaging was performed through HPC-osteoblast contacted cells to identify transferred material.
The weighted colocalization coefficients were calculated using the Zeiss LSM software (Zeiss). Briefly, the weighted colocalizaton coefficients represent the number of red pixels (N-Rh-PE) that colocalize with green pixels (Rab5, Rab7, 2×FYVE, SARA) divided by the total number of red pixels.
Fixation and immunostaining. HPC and osteoblast co-cultures were fixed with 4% paraformaldehyde for 15 min at room temperature followed by a 1×PBS wash. Cells were blocked and permeablized in 1×PBS with 10 mg ml -1 of BSA and 0.3% tween-20. Cells were stained at 4 °C for approximately 15 h with anti-cd45 (Calbiochem), anti-AC133 (1:10, prominin-1; Miltenyi Biotec), anti-CD49d (Calbiochem), anti-SARA (Santa Cruz Biotechnology), anti-Smad2/3 (BD Biosciences) and anti-SDF-1 (Santa Cruz Biotechnology) antibodies. Cells were washed gently with 1×PBS followed by incubation with Alexa-488 goat anti-mouse antibody (Invitrogen) or Cy3-goat anti-rabbit antibody (Jackson ImmunoResearch) for 1 h at room temperature. Cells were washed following secondary antibody with 1×PBS and mounted in Flouromount-G (Southern Biotech) for imaging. All antibodies other than anti-AC133 were used at a 1:500 dilution.
Scanning electron microscopy. Cells were rinsed twice with PBS and fixed with 2% glutaraldehyde in 0.1 mol l -1 Na-cacodylate buffer (with 0.1 mol l -1 sucrose) at pH 7.4 for 12 h. They were subsequently treated with 1% tannic acid in 0.15 mol l -1 Na-cacodylate at pH 7.4 for 1 h and post-fixed with 1% osmium tetroxide in 0.1 mol l -1 Na-cacodylate at pH 7.4 for 1 h. Samples were dehydrated in a graded ethanol series.
Statistical analysis. Error bars represent standard deviations and Student t-tests
were used as a statistical test for all data.
Note: Supplementary Information is available on the Nature Cell Biology website.
